Effect of lymphadenectomy extent on advanced gastric cancer located in the cardia and fundus

World Journal of Gastroenterology

Volumn 14, Issue 26, 2008, Pages 4216-4221

  Huang, Chang Ming ^a   Lin, Bi Juan ^a   Lu, Hui Shan ^a   Zhang, Xiang Fu ^a   Li, Ping ^a   Xie, Jian Wei ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Lymph node metastasis; Lymphadenectomy; Prognosis; Stomach neoplasms; Surgery

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CARDIA; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HUMAN; LINEAR REGRESSION ANALYSIS; LYMPH NODE DISSECTION; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PROGNOSIS; STOMACH CANCER; STOMACH FUNDUS; SURVIVAL RATE; SURVIVAL TIME; AGED; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; STOMACH TUMOR;

ADULT; AGED; CARDIA; FEMALE; GASTRIC FUNDUS; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 54049108588     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.4216     Document Type: Article

References (34)

1. Volpe CM, Driscoll DL, Douglass HO Jr. Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes. Ann Surg Oncol 2000; 7: 139-144
2. Di Martino N, Izzo G, Cosenza A, Vicenzo L, Monaco L, Torelli F, Basciotti A, Brillantino A, Marra A. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?] Suppl Tumori 2005; 4: S84-S85
3. Kulig J, Popiela T, Kolodziejczyk P, Sierzega M, Szczepanik A. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial. Am J Surg 2007; 193: 10-15
4. Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart-K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 2004; 22: 2069-2077
5. Marubini E, Bozzetti F, Miceli R, Bonfanti G, Gennari L. Lymphadenectomy in gastric cancer: prognostic role and therapeutic implications. Eur J Surg Oncol 2002; 28: 406-412
6. Yokota T, Ishiyama S, Salto T, Teshima S, Narushima Y, Murata K, Iwamoto K, Yashima R, Yamauchi H, Kikuchi S. Lymph node metastasis as a significant prognostic factor in gastric cancer: a multiple logistic regression analysis. Scand J Gastroenterol 2004; 39: 380-384
7. Rodriguez Santiago JM, Munoz E, Marti M, Quintana S, Veloso E, Marco C. Metastatic lymph node ratio as a prognostic factor in gastric cancer. Eur J Surg Oncol 2005; 31: 59-66
8. Griffiths EA, Pritchard SA, Mapstone NP, Welch IM. Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology - an update for the surgical oncologist. World J Surg Oncol 2006; 4: 82
9. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma. 2nd English Edition-Gastric Cancer 1998; 1: 10-24
10. Chien CR, Chen SW, Hsieh CY, Liang JA, Yang SN, Huang CY, Lin FJ. Retrospective comparison of The AJCC 5th edition classification for nasopharyngeal carcinoma with the AJCC 4th edition: an experience in Taiwan. Jpn J Clin Oncol 2001; 31: 363-369
11. Kubo A, Corley DA. Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer 2002; 95: 2096-2102
12. Cai L, Zheng ZL, Zhang ZF. Risk factors for the gastric cardia cancer: a Case-control study in Fujian Province. World J Gastroenterol 2003; 9: 214-218
13. Mueller JD, Stein HJ, Oyang T, Natsugoe S, Feith M, Werner M, Rudiger Siewert J. Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction. Cancer 2000; 89: 1874-1882
14. Kim DY, Joo JK, Ryu SY, Park YK, Kim YJ, Kim SK. Clinicopathological characteristics and prognosis of carcinoma of the gastric cardia. Dig Surg 2006; 23: 313-318
15. Bruno L, Nesi G, Montinaro F, Carassale G, Lassig R, Boddi V, Bechi P, Cortesini C. Clinicopathologic findings and results of surgical treatment in cardiac adenocarcinoma. J Surg Oncol 2000; 74: 33-35
16. Degiuli M, Sasako M, Ponti A, Calvo F. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer 2004; 90: 1727-1732
17. de Manzoni G, Morgagni P, Roviello F, Di Leo A, Saragoni L, Marrelli D, Guglielmi A, Carli A, Folli S, Cordiano C. Nodal abdominal spread in adenocarcinoma of the cardia. Results of a multicenter prospective study. Gastric Cancer 1998; 1: 146-151
18. Koufuji K, Shirouzu K, Aoyagi K, Yano S, Miyagi M, Imaizumi T, Takeda J. Surgery and clinicopathological features of gastric adenocarcinoma involving the esophago-gastric junction. Kurume Med J 2005; 52: 73-79
19. Ichikura T, Ogawa T, Kawabata T, Chochi K, Sugasawa H, Mochizuki H. Is adenocarcinoma of the gastric cardia a distinct entity independent of subcardial carcinoma? World J Surg 2003; 27: 334-338
20. Shimoyama S, Yasuda H, Hashimoto M, Tatsutomi Y, Aoki F, Mafune K, Kaminishi M. Accuracy of linear-array EUS for preoperative staging of gastric cardia cancer. Gastrovintest Endosc 2004; 60: 50-55
21. Rasanen JV, Sihvo EI, Knuuti MJ, Minn HR, Luostarinen ME, Laippala P, Viljanen T, Salo JA. Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction. Ann Surg Oncol 2003; 10: 954-960
22. Baxter NN, Tuttle TM. Inadequacy of lymph node staging in gastric cancer patients: a population-based study. Ann Surg Oncol 2005; 12: 981-987
23. Bouvier AM, Haas O, Piard F, Roignot P. Bonithon-Kopp C. Faivre J. How many nodes must be examined to accurately stage gastric carcinomas? Results from a population based studv. Cancer 2002; 94: 2862-2866
24. Saito H, Fukumoto Y, Osaki T, Fukuda K, Tatebe S, Tsujitani S, Ikeguchi M. Distinct recurrence pattern and outcome of adenocarcinoma of the gastric cardia in comparison with carcinoma of other regions of the stomach. World J Surg 2006; 30: 1864-1869
25. Liu KJ, Loewen M, Atten MJ, Millikan K, Tebbit C, Walter RJ. The survival of stage III gastric cancer patients is affected of the number of lymph nodes removed. Surgery 2003 134: 639-644; discussion 644-646
26. Barbour AP, Rizk NP, Gonen M, Tang B, Barns MS, Rusch VW, Coit DG, Brennan MF Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome. Ann Surg Oncol 2007; 14: 806-316
27. Gee DW, Rattner DW. Management of gastroesophageal tumors. Oncologist 2007; 12: 175-185
28. Schwarz RE, Smith DD. Clinical impact of lympha-denectomy extent in resectable gastric cancer of advanced stage. Ann Surg Oncol 2007; 14: 317-328
29. Smith DD, Schwarz RR, Schwarz RE. Impact of total, lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol 2005; 23: 7114-7124
30. Lee HK, Yang HK, Kim WH, Lee KU, Choe KJ, Kim JP. Influence of the number of lymph nodes examined on staging of gastric cancer. Br J Surg 2001; 88: 1408-1412
31. Wu ZY, Li JH, Zhan WH, He YL, Wan J. Effect of lymph node micrometastases on prognosis of gastric carcinoma. World J Gastroenterol 2007; 13: 4122-4125
32. del Casar JM, Corte MD, Alvarez A, Garcia I, Bongera M, Gonzalez LO, Garcia-Muniz JL, Allende MT, Astudillo A, Vizoso FJ. Lymphatic and/ or blood vessel invasion in gastric cancer: relationship with clinicopathological parameters, biological factors and prognostic significance. J Cancer Res Chn Oncol 2008; 134: 153-161
33. Kim DY, Seo KW, Joo JK, Park YK, Ryu SY, Kim HR, Kim YJ, Kim SK. Prognostic factors in patients with. node-negative gastric carcinoma: a comparison with node-positive gastric carcinoma. World J Gastroenterol 2006; 12: 1182-1186
34. Johnson PM, Porter CA, Richardi R, Baxter NN, Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol 2006; 24: 3570-3575